Patterns of anemia during malaria

Archive ouverte

Jauréguiberry, Stéphane | Ndour, Papa Alioune | Thellier, Marc | Caumes, Eric | Buffet, Pierre

Edité par CCSD ; Elsevier -

International audience. We read with interest the article by Rehman et al. on post-artesunate hemolysis (PADH). 1 Hemolysis is indeed commonly associated with the class of artemisinin drugs when used for the treatment of severe malaria. Their review confirmed the high incidence of this adverse event related to the mode of action of artemisinins and the physiological role of the spleen. 2 As the authors wisely pointed out, delayed hemolysis should not jeopardize the deployment of artesunate as the first-line treatment of severe malaria worldwide. While PADH is indeed rarely (if ever) fatal, artesunate significantly reduces mortality as compared to quinine, markedly so in patients with parasitemia greater than 10% on admission. 3 Importantly, PADH has been further characterized by a pathophysiological study in travelers treated with artesunate for severe malaria. 4 Early peak concentrations of circulating once-infected erythrocytes are predictive for the occurrence of PADH and may therefore serve as a future candidate marker for PADH. Rehman et al. referred to different anemia patterns in their analysis of published reports. This definition was based on initial descriptions by Zoller et al. 5 and on a more refined definition proposed in a closed meeting organized by the Medicine for Malaria Venture (MMV) in March 2013 in Vienna (http://www.mmv.org/sites/default/files/uploads/docs/events/2013/InjectableArtesunateExpertGroupMeeting.pdf) 6 and later published in the above mentioned pathophysiological paper. 4 Whereas initial reports were acknowledged in the article by Rehman et al., the optimized nosological classification was not referenced in the manuscript. This omission is likely due to the disclosure in the MMV report (which became publicly available in 2013) of the then unpublished, optimized case definition proposed by our group, without precise referencing of the source of that particular set of information. Sharing unpublished results or concepts during subject-specific meetings, like the one efficiently organized by MMV in Vienna, is important as it allows the malaria community to adapt rapidly and efficiently to new problems with a public health impact. When reports of such meetings carefully acknowledge all respective contributions, this ultimately contributes to maintaining rich exchanges between attendees.

Suggestions

Du même auteur

Delayed-Onset Hemolytic Anemia in Patients with Travel-Associated Severe Malaria Treated with Artesunate, France, 2011–2013

Archive ouverte | Jauréguiberry, Stéphane | CCSD

French Artesunate Working Group. International audience. Artesunate is the most effective treatment for severe malaria. However, delayed-onset hemolytic anemia has been observed in ≈20% of travelers who receive arte...

Plasmodium falciparum Clearance Is Rapid and Pitting Independent in Immune Malian Children Treated With Artesunate for Malaria

Archive ouverte | Ndour, Papa Alioune | CCSD

International audience. Background. In Plasmodium falciparum-infected patients treated with artemisinins, parasitemia declines through so-called pitting, an innate splenic process that transforms infected red blood ...

Propensity Score Analysis of Artesunate Versus Quinine for Severe Imported Plasmodium falciparum Malaria in France

Archive ouverte | El Ket, Nermine | CCSD

International audience. Background: Little is known on the use of artesunate compared with quinine for the treatment of imported malaria cases in nonendemic countries with a high level of care. Therefore, we compare...

Chargement des enrichissements...